Hoth Therapeutics, Inc.RKTO

$1.08-0.02 (-1.82%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$17M

Micro-cap

-74%

2019 — today

10-Year Price

-99%

2019 — today

52-Week Range

$0.51$2.22

Current $1.08· 33%

Hoth Therapeutics, Inc. specializes in developing next-generation therapeutic approaches for a range of dermatological ailments. Its active development pipeline includes investigational treatments targeting conditions such as atopic dermatitis (more commonly known as eczema), persistent wounds, psoriasis, asthma, and acne. A key offering from the company is the BioLexa Platform, a proprietary drug compound system specifically engineered to address eczema. Founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017, the firm's main operations are situated in Hoboken, New Jersey.

Valuation in context

P/E ratio

-1.3

N/A

Not meaningful — company is unprofitable

P/B ratio

4.1

Above average

Pricier than usual over the last 10 years

FCF Yield

-59.0%

Around average

Around the 10-year average

Free · No credit card needed

Get alerted when RKTO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.